Ian Hamilton-Craig

Summary

Publications

  1. pmc Fenofibrate therapy in carnitine palmitoyl transferase type 2 deficiency
    I Hamilton-Craig
    Griffith University School of Medicine and Gold Coast University Hospital, Southport, Gold Coast, QLD 4215, Australia
    Case Report Med 2012:163173. 2012
  2. doi request reprint Use of fibrates in clinical practice: Queensland Lipid Group consensus recommendations
    Ian Hamilton-Craig
    Department of Cardiology, Gold Coast Hospital, Griffith University School of Medicine, and Griffith Health Institute, Heart Foundation Research Centre, Southport, Queensland, Australia
    Int J Evid Based Healthc 10:181-90. 2012
  3. pmc Combination therapy of statin and ezetimibe for the treatment of familial hypercholesterolemia
    Ian Hamilton-Craig
    Griffith University School of Medicine, Southport, Queensland, Australia
    Vasc Health Risk Manag 6:1023-37. 2010
  4. doi request reprint At sea with SEAS: the first clinical endpoint trial for ezetimibe, treatment of patients with mild to moderate aortic stenosis, ends with mixed results and more controversy
    Ian Hamilton-Craig
    Department of Cardiology, Griffith University School of Medicine, Gold Coast Hospital, Southport, Queensland 4215, Australia
    Heart Lung Circ 18:343-6. 2009

Collaborators

Detail Information

Publications4

  1. pmc Fenofibrate therapy in carnitine palmitoyl transferase type 2 deficiency
    I Hamilton-Craig
    Griffith University School of Medicine and Gold Coast University Hospital, Southport, Gold Coast, QLD 4215, Australia
    Case Report Med 2012:163173. 2012
    ..This suggests additional methods to avoid rhabdomyolysis in patients with CPT2 deficiency should accompany fibrate therapy, including avoidance of muscular overexertion, dehydration, and heat exposure...
  2. doi request reprint Use of fibrates in clinical practice: Queensland Lipid Group consensus recommendations
    Ian Hamilton-Craig
    Department of Cardiology, Gold Coast Hospital, Griffith University School of Medicine, and Griffith Health Institute, Heart Foundation Research Centre, Southport, Queensland, Australia
    Int J Evid Based Healthc 10:181-90. 2012
    ..Fibrates are variably effective in lowering low-density cholesterol levels. Available fibrates include gemfibrozil, fenofibrate, bezafibrate, etiofibrate and ciprofobrate; only fenofibrate and gemfibrozil are available in Australia...
  3. pmc Combination therapy of statin and ezetimibe for the treatment of familial hypercholesterolemia
    Ian Hamilton-Craig
    Griffith University School of Medicine, Southport, Queensland, Australia
    Vasc Health Risk Manag 6:1023-37. 2010
    ..One large long-term randomized controlled clinical outcomes trial is in progress in non-FH patients to determine the efficacy and safety of ezetimibe therapy; it is unlikely that such a trial will ever be performed in patients with FH...
  4. doi request reprint At sea with SEAS: the first clinical endpoint trial for ezetimibe, treatment of patients with mild to moderate aortic stenosis, ends with mixed results and more controversy
    Ian Hamilton-Craig
    Department of Cardiology, Griffith University School of Medicine, Gold Coast Hospital, Southport, Queensland 4215, Australia
    Heart Lung Circ 18:343-6. 2009
    ..9% vs. 7.0%, p=0.03 and 4.1% vs. 2.5%, p=0.05, respectively). These differences were not related to any form of cancer and did not increase with increased duration of therapy...